274 related articles for article (PubMed ID: 24884893)
1. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
2. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
3. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
4. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
[TBL] [Abstract][Full Text] [Related]
5. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
Zhao H; Zhu F; Sun J; Meng X
Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
8. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
10. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
[TBL] [Abstract][Full Text] [Related]
11. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
12. Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies.
Yu L; Chen J
Diagn Pathol; 2012 Dec; 7():171. PubMed ID: 23217001
[TBL] [Abstract][Full Text] [Related]
13. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
15. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
16. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
[TBL] [Abstract][Full Text] [Related]
19. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
